Potassium clavulanate CAS:61177-45-5

Potassium clavulanate is frequently utilized in combination with antibiotics to combat bacterial infections that have developed resistance to standard treatments. The combination of potassium clavulanate with antibiotics such as amoxicillin creates a synergistic effect, allowing for increased bacterial killing by preventing the breakdown of the antibiotic by bacterial enzymes. This combination therapy is often prescribed for various types of infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media. By expanding the spectrum of activity against both gram-positive and gram-negative bacteria, potassium clavulanate enhances the effectiveness of the accompanying antibiotic, thus providing a broader coverage of pathogens. Healthcare providers consider the microbial profile of the infection, the site of infection, and the patient's clinical condition when choosing a potassium clavulanate-containing regimen. This combination therapy is particularly useful in treating complicated infections or cases where broad-spectrum coverage is required. Overall, potassium clavulanate plays a pivotal role in combating antibiotic-resistant bacteria and improving treatment outcomes in patients with a wide range of bacterial infections.